Last reviewed 2026-05-15 · How we verify

Bailing Capsules in combination Guben Kechuan Granules

Second Affiliated Hospital, School of Medicine, Zhejiang University · FDA-approved active Small molecule Quality 2/100

Bailing Capsules in combination Guben Kechuan Granules is a Small molecule drug developed by Second Affiliated Hospital, School of Medicine, Zhejiang University. It is currently FDA-approved. Also known as: Bailing Capsules, Guben Kechuan Granules.

Bailing Capsules in combination with Guben Kechuan Granules, developed by the Second Affiliated Hospital, School of Medicine, Zhejiang University, is a marketed drug with a key composition patent expiring in 2028. The drug's primary strength lies in its unique combination therapy, which differentiates it in the market. The primary risk is the patent expiry in 2028, which could lead to increased competition from generics.

At a glance

Generic name	Bailing Capsules in combination Guben Kechuan Granules
Also known as	Bailing Capsules, Guben Kechuan Granules
Sponsor	Second Affiliated Hospital, School of Medicine, Zhejiang University
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Clinical Study on the Treatment of Stable Bronchiectasis With Bailing Capsules Combined With Guben Kechuan Granules (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Bailing Capsules in combination Guben Kechuan Granules CI brief — competitive landscape report
Bailing Capsules in combination Guben Kechuan Granules updates RSS · CI watch RSS
Second Affiliated Hospital, School of Medicine, Zhejiang University portfolio CI

Frequently asked questions about Bailing Capsules in combination Guben Kechuan Granules

What is Bailing Capsules in combination Guben Kechuan Granules?

Bailing Capsules in combination Guben Kechuan Granules is a Small molecule drug developed by Second Affiliated Hospital, School of Medicine, Zhejiang University.

Who makes Bailing Capsules in combination Guben Kechuan Granules?

Bailing Capsules in combination Guben Kechuan Granules is developed and marketed by Second Affiliated Hospital, School of Medicine, Zhejiang University (see full Second Affiliated Hospital, School of Medicine, Zhejiang University pipeline at /company/second-affiliated-hospital-school-of-medicine-zhejiang-university).

Is Bailing Capsules in combination Guben Kechuan Granules also known as anything else?

Bailing Capsules in combination Guben Kechuan Granules is also known as Bailing Capsules, Guben Kechuan Granules.

What development phase is Bailing Capsules in combination Guben Kechuan Granules in?

Bailing Capsules in combination Guben Kechuan Granules is FDA-approved (marketed).

Manufacturer: Second Affiliated Hospital, School of Medicine, Zhejiang University — full pipeline
Also known as: Bailing Capsules, Guben Kechuan Granules

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing